drugset / Trial / NCT06755996

Dexmedetomidine Nasal Spray and Pediatric Bronchoscopy

NCT06755996

Completed 150 enrolled Tongji Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

To observe the sedative effect of using dexmedetomidine nasal spray combined with remimazolam for pediatric bronchoscopy diagnosis and treatment, provide a safer and more comfortable anesthesia plan for pediatric bronchoscopy diagnosis and treatment

Timeline

Start
2025-01-07
Primary completion
2025-08-31
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 3 ug/kg Other
Background Remimazolam Small molecule 0.5 mg/kg

Indications

No indication recorded.